Khalid Matin

829 total citations
29 papers, 348 citations indexed

About

Khalid Matin is a scholar working on Oncology, Surgery and General Health Professions. According to data from OpenAlex, Khalid Matin has authored 29 papers receiving a total of 348 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 6 papers in Surgery and 5 papers in General Health Professions. Recurrent topics in Khalid Matin's work include Colorectal Cancer Treatments and Studies (8 papers), Pancreatic and Hepatic Oncology Research (5 papers) and Cancer Treatment and Pharmacology (4 papers). Khalid Matin is often cited by papers focused on Colorectal Cancer Treatments and Studies (8 papers), Pancreatic and Hepatic Oncology Research (5 papers) and Cancer Treatment and Pharmacology (4 papers). Khalid Matin collaborates with scholars based in United States, Australia and Germany. Khalid Matin's co-authors include Jordan M. Alpert, Richard Brown, Bonny Morris, Maria D. Thomson, Sunil V. Rao, Rahman Shah, Kelly C. Rogers, Raza Askari, Ramesh K. Ramanathan and Amy Schmotzer and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Anesthesiology.

In The Last Decade

Khalid Matin

29 papers receiving 346 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Khalid Matin United States	11	129	89	84	68	55	29	348
Roberto Vespignani Italy	6	144 1.1×	71 0.8×	50 0.6×	46 0.7×	38 0.7×	15	387
Mike Gorenchtein United States	5	54 0.4×	43 0.5×	78 0.9×	26 0.4×	45 0.8×	11	427
David W. Dougherty United States	11	83 0.6×	42 0.5×	36 0.4×	51 0.8×	91 1.7×	34	379
Ana Denise Zazula Brazil	9	36 0.3×	38 0.4×	49 0.6×	57 0.8×	29 0.5×	15	353
Lindy Berkman United Kingdom	8	114 0.9×	22 0.2×	98 1.2×	24 0.4×	70 1.3×	13	266
Conan J O O’Brien United States	7	78 0.6×	86 1.0×	31 0.4×	40 0.6×	8 0.1×	9	301
April Barbour United States	5	267 2.1×	50 0.6×	50 0.6×	69 1.0×	72 1.3×	7	494
Habeeb Majeed Canada	11	138 1.1×	33 0.4×	78 0.9×	59 0.9×	88 1.6×	20	459
Do-Kyong Kim South Korea	7	134 1.0×	20 0.2×	54 0.6×	29 0.4×	67 1.2×	38	279
Natasha S. Becker United States	10	203 1.6×	48 0.5×	244 2.9×	37 0.5×	82 1.5×	14	424

Countries citing papers authored by Khalid Matin

Since Specialization

Citations

This map shows the geographic impact of Khalid Matin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Khalid Matin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Khalid Matin more than expected).

Fields of papers citing papers by Khalid Matin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Khalid Matin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Khalid Matin. The network helps show where Khalid Matin may publish in the future.

Co-authorship network of co-authors of Khalid Matin

This figure shows the co-authorship network connecting the top 25 collaborators of Khalid Matin. A scholar is included among the top collaborators of Khalid Matin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Khalid Matin. Khalid Matin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sinicrope, Frank A., Fang‐Shu Ou, Dirk Arnold, et al.. (2025). Randomized trial of standard chemotherapy alone or combined with atezolizumab as adjuvant therapy for patients with stage III deficient DNA mismatch repair (dMMR) colon cancer (Alliance A021502; ATOMIC).. Journal of Clinical Oncology. 43(17_suppl). 8 indexed citations

Tu, Shin‐Ping, Xi Zhu, Daniel K. Sewell, et al.. (2024). Patient care in complex Sociotechnological ecosystems and learning health systems. Learning Health Systems. 8(S1). e10427–e10427. 1 indexed citations

Ko, Andrew H., Mark M. Zalupski, Raed Moh’d Taiseer Al-Rajabi, et al.. (2023). A phase 2 basket trial of ulixertinib (BVD-523) in combination with hydroxychloroquine in patients with advanced gastrointestinal malignancies harboring MAPK pathway mutations (BVD-523-HCQ).. Journal of Clinical Oncology. 41(16_suppl). TPS4174–TPS4174. 1 indexed citations

Poklepovic, Andrew, Emma C. Fields, Dipankar Bandyopadhyay, et al.. (2021). A phase 1 study of neoadjuvant chemotherapy followed by concurrent chemoradiation with gemcitabine, sorafenib, and vorinostat in pancreatic cancer.. Journal of Clinical Oncology. 39(15_suppl). e16268–e16268. 8 indexed citations

Enzinger, Andrea C., Hajime Uno, Nadine J. McCleary, et al.. (2020). The Effect of Disclosing Life Expectancy Information on Patients' Prognostic Understanding: Secondary Outcomes From a Multicenter Randomized Trial of a Palliative Chemotherapy Educational Intervention. Journal of Pain and Symptom Management. 61(1). 1–11.e3. 7 indexed citations

Shah, Rahman, et al.. (2019). Bivalirudin with a post‐procedure infusion versus heparin monotherapy for the prevention of stent thrombosis. Catheterization and Cardiovascular Interventions. 94(2). 210–215. 7 indexed citations

Bandyopadhyay, Dipankar, et al.. (2019). Adjuvant radiation therapy for T4 non-rectal colon adenocarcinoma provides a cause-specific survival advantage: A SEER database analysis. Radiotherapy and Oncology. 133. 50–53. 12 indexed citations

Fields, Emma C., Brian Kaplan, Jeremy Karlin, et al.. (2019). Phase 1 Study of Neoadjuvant Short-Course Radiation Therapy Concurrent With Infusional 5-Fluorouracil for the Treatment of Locally Advanced Rectal Cancer. Advances in Radiation Oncology. 4(4). 605–612. 3 indexed citations

Alpert, Jordan M., Bonny Morris, Maria D. Thomson, et al.. (2019). Patient access to clinical notes in oncology: A mixed method analysis of oncologists’ attitudes and linguistic characteristics towards notes. Patient Education and Counseling. 102(10). 1917–1924. 20 indexed citations

10.

Alpert, Jordan M., Bonny Morris, Maria D. Thomson, Khalid Matin, & Richard Brown. (2018). Identifying How Patient Portals Impact Communication in Oncology. Health Communication. 34(12). 1395–1403. 33 indexed citations

11.

Alpert, Jordan M., Bonny Morris, Maria D. Thomson, Khalid Matin, & Richard Brown. (2018). Implications of Patient Portal Transparency in Oncology: Qualitative Interview Study on the Experiences of Patients, Oncologists, and Medical Informaticists. JMIR Cancer. 4(1). e5–e5. 30 indexed citations

12.

Alpert, Jordan M., Bonny Morris, Maria D. Thomson, et al.. (2018). OpenNotes in oncology: oncologists’ perceptions and a baseline of the content and style of their clinician notes. Translational Behavioral Medicine. 9(2). 347–356. 17 indexed citations

13.

Bandyopadhyay, Dipankar, et al.. (2017). Adjuvant Radiation Therapy for T4 Nonrectal Colon Adenocarcinoma Provides a Cause-Specific Survival Advantage: A SEER Database Analysis. International Journal of Radiation Oncology*Biology*Physics. 99(2). E171–E172. 1 indexed citations

14.

Shah, Rahman, Kelly C. Rogers, Khalid Matin, Raza Askari, & Sunil V. Rao. (2015). An updated comprehensive meta-analysis of bivalirudin vs heparin use in primary percutaneous coronary intervention. American Heart Journal. 171(1). 14–24. 34 indexed citations

15.

Avery, Robert A., et al.. (2011). Natural Killer T-Cell Lymphoma Presenting As Adrenal Mass and Partial Adrenal Insufficiency Followed by CNS Involvement. Journal of Clinical Oncology. 29(15). e431–e433. 2 indexed citations

16.

Brell, Joanna M., Khalid Matin, Terry Evans, et al.. (2009). Phase II Study of Docetaxel and Gefitinib as Second-Line Therapy in Gemcitabine Pretreated Patients with Advanced Pancreatic Cancer. Oncology. 76(4). 270–274. 29 indexed citations

17.

Patel, Hitendra, Ronald G. Stoller, Miklos Auber, et al.. (2006). Phase II study of rubitecan, an oral camptothecin in patients with advanced colorectal cancer who have failed previous 5-fluorouracil based chemotherapy. Investigational New Drugs. 24(4). 359–363. 10 indexed citations

18.

Matin, Khalid, Samuel A. Jacobs, Thomas J. Richards, et al.. (2005). A Phase I/II Study of Trimetrexate and Capecitabine in Patients With Advanced Refractory Colorectal Cancer. American Journal of Clinical Oncology. 28(5). 439–444. 4 indexed citations

19.

Matin, Khalid, Merrill J. Egorin, Michael Ballesteros, et al.. (2002). Phase I and pharmacokinetic study of vinblastine and high-dose megestrol acetate. Cancer Chemotherapy and Pharmacology. 50(3). 179–185. 8 indexed citations

20.

Matin, Khalid, et al.. (1991). INOTROPISM OF MAGNESIUM. Anesthesiology. 75(3). A374–A374. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact